Drug
Norgestimate And Ethinyl Estradiol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Metrorrhagia | 86 | 23.0 | 23.4 | signal |
| 2 | Menstruation Irregular | 100 | 17.4 | 17.8 | signal |
| 3 | Dysmenorrhoea | 47 | 16.6 | 16.8 | signal |
| 4 | Menorrhagia | 68 | 15.8 | 16.0 | signal |
| 5 | Menstruation Delayed | 31 | 13.8 | 13.9 | signal |
| 6 | Vaginal Haemorrhage | 102 | 11.0 | 11.3 | signal |
| 7 | Coeliac Disease | 23 | 10.8 | 10.9 | signal |
| 8 | Ovarian Cyst | 21 | 9.6 | 9.7 | signal |
| 9 | Product Substitution Issue | 116 | 9.3 | 9.5 | signal |
| 10 | Unintended Pregnancy | 21 | 9.3 | 9.3 | signal |
| 11 | Mood Swings | 52 | 7.5 | 7.6 | signal |
| 12 | Gallbladder Disorder | 29 | 7.5 | 7.5 | signal |
| 13 | Breast Pain | 17 | 7.3 | 7.4 | signal |
| 14 | Pelvic Pain | 28 | 7.1 | 7.1 | signal |
| 15 | Cholelithiasis | 50 | 7.0 | 7.1 | signal |
| 16 | Product Packaging Issue | 14 | 7.0 | 7.0 | signal |
| 17 | Cholecystectomy | 17 | 6.9 | 6.9 | signal |
| 18 | Dermatitis Atopic | 74 | 6.8 | 6.9 | signal |
| 19 | Complication Of Device Insertion | 26 | 6.5 | 6.5 | signal |
| 20 | Vaginal Discharge | 14 | 6.4 | 6.4 | signal |
| 21 | Amenorrhoea | 23 | 6.3 | 6.4 | signal |
| 22 | Initial Insomnia | 14 | 6.3 | 6.3 | signal |
| 23 | Affect Lability | 13 | 6.2 | 6.2 | signal |
| 24 | Abortion Induced | 12 | 5.9 | 5.9 | signal |
| 25 | Cholecystitis | 15 | 5.8 | 5.8 | signal |
| 26 | Abdominal Pain Lower | 31 | 5.6 | 5.7 | signal |
| 27 | Mood Altered | 33 | 5.6 | 5.6 | signal |
| 28 | Panic Attack | 41 | 5.2 | 5.2 | signal |
| 29 | Injury | 79 | 5.1 | 5.2 | signal |
| 30 | Sleep Disorder Due To A General Medical Condition | 18 | 5.1 | 5.1 | signal |
| 31 | Pulmonary Embolism | 106 | 5.1 | 5.2 | signal |
| 32 | Product Dose Omission | 71 | 4.9 | 5.0 | signal |
| 33 | Impaired Work Ability | 21 | 4.5 | 4.5 | signal |
| 34 | Deep Vein Thrombosis | 62 | 4.4 | 4.4 | signal |
| 35 | Genital Haemorrhage | 12 | 4.3 | 4.3 | signal |
| 36 | Vitamin D Deficiency | 9 | 4.3 | 4.3 | signal |
| 37 | Pharmaceutical Product Complaint | 24 | 4.2 | 4.2 | signal |
| 38 | Pregnancy | 18 | 4.1 | 4.1 | signal |
| 39 | Maternal Exposure During Pregnancy | 78 | 4.1 | 4.1 | signal |
| 40 | Mydriasis | 11 | 4.0 | 4.0 | signal |
| 41 | Acne | 65 | 3.9 | 4.0 | signal |
| 42 | Crying | 31 | 3.9 | 3.9 | signal |
| 43 | Intentional Dose Omission | 23 | 3.9 | 3.9 | signal |
| 44 | Pharyngitis Streptococcal | 9 | 3.8 | 3.8 | signal |
| 45 | Injection Site Urticaria | 20 | 3.8 | 3.8 | signal |
| 46 | Bipolar Disorder | 9 | 3.8 | 3.8 | signal |
| 47 | Hunger | 11 | 3.8 | 3.8 | signal |
| 48 | Hallucination, Auditory | 13 | 3.8 | 3.8 | signal |
| 49 | Libido Decreased | 10 | 3.7 | 3.7 | signal |
| 50 | Emotional Disorder | 25 | 3.7 | 3.7 | signal |
| 51 | Depression | 177 | 3.6 | 3.7 | signal |
| 52 | Exposure During Pregnancy | 48 | 3.6 | 3.6 | signal |
| 53 | Skin Haemorrhage | 11 | 3.5 | 3.5 | signal |
| 54 | Scar | 13 | 3.5 | 3.5 | signal |
| 55 | Anxiety | 209 | 3.4 | 3.5 | signal |
| 56 | Sleep Apnoea Syndrome | 13 | 3.1 | 3.1 | signal |
| 57 | Eczema | 34 | 3.1 | 3.1 | signal |
| 58 | Migraine | 64 | 3.1 | 3.1 | signal |
| 59 | Thrombosis | 54 | 3.1 | 3.1 | signal |
| 60 | Decreased Activity | 7 | 3.0 | 3.0 | signal |
| 61 | Procedural Pain | 18 | 3.0 | 3.0 | signal |
| 62 | Middle Insomnia | 12 | 3.0 | 3.0 | signal |
| 63 | Pulmonary Thrombosis | 7 | 2.9 | 3.0 | signal |
| 64 | Eye Infection | 7 | 2.9 | 2.9 | signal |
| 65 | Therapy Change | 6 | 2.9 | 2.9 | signal |
| 66 | Suicidal Ideation | 57 | 2.9 | 2.9 | signal |
| 67 | Dermatitis Contact | 7 | 2.8 | 2.8 | signal |
| 68 | Stress | 44 | 2.8 | 2.8 | signal |
| 69 | Embedded Device | 6 | 2.8 | 2.8 | signal |
| 70 | Product Dose Omission In Error | 16 | 2.7 | 2.7 | signal |
| 71 | Eye Swelling | 22 | 2.7 | 2.7 | signal |
| 72 | Complication Of Device Removal | 10 | 2.7 | 2.7 | signal |
| 73 | Anger | 20 | 2.7 | 2.7 | signal |
| 74 | Skin Fissures | 11 | 2.7 | 2.7 | signal |
| 75 | Central Nervous System Lesion | 8 | 2.7 | 2.7 | signal |
| 76 | Abnormal Dreams | 16 | 2.6 | 2.7 | signal |
| 77 | Cold Sweat | 10 | 2.6 | 2.6 | signal |
| 78 | Disease Recurrence | 27 | 2.6 | 2.6 | signal |
| 79 | Injection Site Discolouration | 7 | 2.6 | 2.6 | signal |
| 80 | Product Quality Issue | 76 | 2.6 | 2.6 | signal |
| 81 | Cyst | 7 | 2.6 | 2.6 | signal |
| 82 | Poor Quality Sleep | 12 | 2.6 | 2.6 | signal |
| 83 | Abdominal Distension | 58 | 2.6 | 2.6 | signal |
| 84 | Muscle Tightness | 9 | 2.6 | 2.6 | signal |
| 85 | Impaired Quality Of Life | 8 | 2.6 | 2.6 | signal |
| 86 | Abdominal Pain Upper | 114 | 2.6 | 2.6 | signal |
| 87 | Injection Site Swelling | 42 | 2.6 | 2.6 | signal |
| 88 | Injection Site Irritation | 7 | 2.5 | 2.5 | signal |
| 89 | Device Dislocation | 24 | 2.5 | 2.6 | signal |
| 90 | Mental Disorder | 24 | 2.5 | 2.5 | signal |
| 91 | Impaired Gastric Emptying | 7 | 2.5 | 2.5 | signal |
| 92 | Pruritus Generalised | 12 | 2.5 | 2.5 | signal |
| 93 | Abortion Spontaneous | 22 | 2.5 | 2.5 | signal |
| 94 | Injection Site Warmth | 11 | 2.5 | 2.5 | signal |
| 95 | Drug Dose Omission | 89 | 2.4 | 2.5 | signal |
| 96 | Nausea | 417 | 2.4 | 2.6 | signal |
| 97 | Discomfort | 32 | 2.4 | 2.4 | signal |
| 98 | Impaired Driving Ability | 6 | 2.4 | 2.4 | no signal |
| 99 | Inappropriate Schedule Of Drug Administration | 38 | 2.4 | 2.4 | signal |
| 100 | Quality Of Life Decreased | 7 | 2.4 | 2.4 | signal |
| 101 | Paranoia | 9 | 2.4 | 2.4 | signal |
| 102 | Irritable Bowel Syndrome | 11 | 2.4 | 2.4 | signal |
| 103 | Irritability | 31 | 2.4 | 2.4 | signal |
| 104 | Fungal Infection | 17 | 2.3 | 2.4 | signal |
| 105 | Thirst | 9 | 2.3 | 2.3 | signal |
| 106 | Sinus Disorder | 10 | 2.3 | 2.3 | signal |
| 107 | Product Administration Error | 10 | 2.3 | 2.3 | signal |
| 108 | Flushing | 51 | 2.3 | 2.3 | signal |
| 109 | Eye Discharge | 5 | 2.3 | 2.3 | no signal |
| 110 | Urticaria | 81 | 2.2 | 2.3 | signal |
| 111 | Swelling Face | 31 | 2.2 | 2.2 | signal |
| 112 | Retching | 10 | 2.2 | 2.2 | signal |
| 113 | Surgery | 27 | 2.1 | 2.2 | signal |
| 114 | Injection Site Pruritus | 31 | 2.1 | 2.2 | signal |
| 115 | Toxic Epidermal Necrolysis | 7 | 2.1 | 2.1 | no signal |
| 116 | Multiple Sclerosis Relapse | 32 | 2.1 | 2.1 | signal |
| 117 | Palpitations | 53 | 2.1 | 2.1 | signal |
| 118 | Drug Dispensing Error | 7 | 2.1 | 2.1 | no signal |
| 119 | Headache | 282 | 2.1 | 2.1 | signal |
| 120 | Therapy Cessation | 23 | 2.1 | 2.1 | signal |
| 121 | Nerve Injury | 5 | 2.1 | 2.1 | no signal |
| 122 | Product Taste Abnormal | 6 | 2.1 | 2.1 | no signal |
| 123 | Fear | 12 | 2.0 | 2.0 | signal |
| 124 | Therapeutic Response Shortened | 14 | 2.0 | 2.0 | signal |
| 125 | Muscle Twitching | 10 | 2.0 | 2.0 | no signal |
| 126 | Nightmare | 15 | 2.0 | 2.0 | no signal |
| 127 | Aphonia | 6 | 2.0 | 2.0 | no signal |
| 128 | Injection Site Rash | 13 | 2.0 | 2.0 | no signal |
| 129 | Caesarean Section | 5 | 2.0 | 2.0 | no signal |
| 130 | Muscle Spasms | 78 | 2.0 | 2.0 | no signal |
| 131 | Accident | 5 | 1.9 | 1.9 | no signal |
| 132 | Pharyngeal Swelling | 4 | 1.9 | 1.9 | no signal |
| 133 | Product Dose Omission Issue | 118 | 1.9 | 1.9 | no signal |
| 134 | Oral Herpes | 8 | 1.9 | 1.9 | no signal |
| 135 | Dry Skin | 54 | 1.9 | 1.9 | no signal |
| 136 | Injection Site Reaction | 28 | 1.9 | 1.9 | no signal |
| 137 | Inappropriate Schedule Of Product Administration | 72 | 1.9 | 1.9 | no signal |
| 138 | Disturbance In Attention | 22 | 1.9 | 1.9 | no signal |
| 139 | Rash Erythematous | 19 | 1.9 | 1.9 | no signal |
| 140 | Product Physical Issue | 8 | 1.8 | 1.8 | no signal |
| 141 | Device Issue | 35 | 1.8 | 1.9 | no signal |
| 142 | Therapeutic Response Unexpected | 18 | 1.8 | 1.8 | no signal |
| 143 | Activities Of Daily Living Impaired | 8 | 1.8 | 1.8 | no signal |
| 144 | Hot Flush | 30 | 1.8 | 1.8 | no signal |
| 145 | Injection Site Erythema | 48 | 1.8 | 1.8 | no signal |
| 146 | Ankylosing Spondylitis | 5 | 1.8 | 1.8 | no signal |
| 147 | No Adverse Event | 68 | 1.8 | 1.8 | no signal |
| 148 | Injection Site Mass | 14 | 1.7 | 1.8 | no signal |
| 149 | Withdrawal Syndrome | 16 | 1.7 | 1.7 | no signal |
| 150 | Emotional Distress | 46 | 1.7 | 1.7 | no signal |
| 151 | Feeling Abnormal | 91 | 1.7 | 1.8 | no signal |
| 152 | Anhedonia | 10 | 1.7 | 1.7 | no signal |
| 153 | Adverse Reaction | 5 | 1.7 | 1.7 | no signal |
| 154 | Drug Exposure During Pregnancy | 13 | 1.7 | 1.7 | no signal |
| 155 | Thinking Abnormal | 7 | 1.7 | 1.7 | no signal |
| 156 | Gastric Disorder | 13 | 1.7 | 1.7 | no signal |
| 157 | Colitis Ulcerative | 16 | 1.7 | 1.7 | no signal |
| 158 | Drug Effect Less Than Expected | 5 | 1.6 | 1.6 | no signal |
| 159 | Rebound Effect | 4 | 1.6 | 1.6 | no signal |
| 160 | Convulsion | 20 | 1.6 | 1.6 | no signal |
| 161 | Psoriasis | 45 | 1.6 | 1.6 | no signal |
| 162 | Apathy | 5 | 1.6 | 1.6 | no signal |
| 163 | Product Prescribing Issue | 7 | 1.6 | 1.6 | no signal |
| 164 | Unevaluable Event | 26 | 1.6 | 1.6 | no signal |
| 165 | Injection Site Pain | 104 | 1.6 | 1.6 | no signal |
| 166 | Post Procedural Haemorrhage | 4 | 1.6 | 1.6 | no signal |
| 167 | Injection Site Bruising | 27 | 1.6 | 1.6 | no signal |
| 168 | Psychotic Disorder | 10 | 1.6 | 1.6 | no signal |
| 169 | Skin Exfoliation | 27 | 1.5 | 1.5 | no signal |
| 170 | Intentional Product Misuse | 28 | 1.5 | 1.5 | no signal |
| 171 | Ocular Hyperaemia | 15 | 1.5 | 1.5 | no signal |
| 172 | Device Breakage | 12 | 1.4 | 1.4 | no signal |
| 173 | Skin Irritation | 14 | 1.4 | 1.4 | no signal |
| 174 | Eye Irritation | 17 | 1.4 | 1.4 | no signal |
| 175 | Inflammatory Bowel Disease | 3 | 1.4 | 1.4 | no signal |
| 176 | Mania | 5 | 1.4 | 1.4 | no signal |
| 177 | Eye Pruritus | 10 | 1.4 | 1.4 | no signal |
| 178 | Complication Associated With Device | 4 | 1.4 | 1.4 | no signal |
| 179 | Pain Of Skin | 8 | 1.4 | 1.4 | no signal |
| 180 | Poor Quality Product Administered | 3 | 1.4 | 1.4 | no signal |
| 181 | Injection Site Discomfort | 3 | 1.3 | 1.3 | no signal |
| 182 | Hereditary Angioedema | 3 | 1.3 | 1.3 | no signal |
| 183 | Product Packaging Quantity Issue | 3 | 1.3 | 1.3 | no signal |
| 184 | Injection Site Haematoma | 4 | 1.3 | 1.3 | no signal |
| 185 | Application Site Pain | 6 | 1.3 | 1.3 | no signal |
| 186 | Serotonin Syndrome | 5 | 1.2 | 1.2 | no signal |
| 187 | Drug Prescribing Error | 5 | 1.2 | 1.2 | no signal |
| 188 | Product Storage Error | 22 | 1.2 | 1.2 | no signal |
| 189 | Device Deployment Issue | 3 | 1.2 | 1.2 | no signal |
| 190 | Schizophrenia | 3 | 1.1 | 1.1 | no signal |
| 191 | Aggression | 12 | 1.1 | 1.1 | no signal |
| 192 | Injection Site Induration | 3 | 1.1 | 1.1 | no signal |
| 193 | Device Expulsion | 15 | 1.1 | 1.1 | no signal |
| 194 | Anorexia | 3 | 1.1 | 1.1 | no signal |
| 195 | Incorrect Product Storage | 3 | 1.0 | 1.0 | no signal |
| 196 | Hair Texture Abnormal | 3 | 1.0 | 1.0 | no signal |
| 197 | Drug Effect Decreased | 12 | 1.0 | 1.0 | no signal |
| 198 | Injection Site Haemorrhage | 17 | 1.0 | 1.0 | no signal |
| 199 | Dystonia | 4 | 0.9 | 0.9 | no signal |
| 200 | Extra Dose Administered | 8 | 0.9 | 0.9 | no signal |
| 201 | Incorrect Dose Administered | 45 | 0.9 | 0.9 | no signal |
| 202 | Intentional Self-injury | 4 | 0.9 | 0.9 | no signal |
| 203 | Drug Effect Incomplete | 7 | 0.9 | 0.9 | no signal |
| 204 | Wrong Technique In Drug Usage Process | 7 | 0.9 | 0.9 | no signal |
| 205 | Device Use Issue | 3 | 0.8 | 0.8 | no signal |
| 206 | Drug Effective For Unapproved Indication | 5 | 0.8 | 0.8 | no signal |
| 207 | Multiple Sclerosis | 8 | 0.8 | 0.8 | no signal |
| 208 | Product Complaint | 4 | 0.7 | 0.7 | no signal |
| 209 | Application Site Erythema | 4 | 0.7 | 0.7 | no signal |
| 210 | Product Preparation Error | 3 | 0.7 | 0.7 | no signal |
| 211 | Needle Issue | 4 | 0.6 | 0.6 | no signal |
| 212 | Device Difficult To Use | 9 | 0.6 | 0.6 | no signal |
| 213 | Device Delivery System Issue | 3 | 0.5 | 0.5 | no signal |